Navigation Links
Bio-Phase II 2.0mm Suture Anchor

ProductsBio-Phase II 2.0mm Suture Anchor
Company Arthrotek (A Biomet Company)
Item Bio-Phase II 2.0mm Suture Anchor
Features 
  • Suture easily slides through the anchor
  • Material resorbs in 915 months
  • Strength retention throughout soft-tissue healing
  • Anchor pull-out strength greater than 1-0 suture breakage
  • Description LactoSorb copolymer is an absorbable co-polymer synthesized from all-natural ingredients: 82% L-Lactic acid and 18% glycolic acid. Unlike the homopolymers in common use such as 100% poly-L-lactic acid (PLLA) or 100% poly-glycolic acid (PGA), LactoSorb copolymer is substantially amorphous (without crystallinity), meaning that its degradation is uniform, precluding the crystalline release associated with degrading homopolymers that have been implicated in late inflammatory reactions. Furthermore, this co-polymer ratio permits the polymer to retain most of its strength for six to eight weeks, which is appropriate for healing, but not so long as to raise concerns about long-term stress shielding of bone. Mass loss, which always follows strength loss for absorbable polymers, occurs in a clinically relevant twelve months (approximately) for LactoSorb copolymer.
    Info Arthrotek (A Biomet Company)
    Customer Service: (800) 348-9500
    Web site: http://www.arthrotek.com

    Related medicine products :

    1. Bio-Phase II 3.0mm Suture Anchor
    2. 2.0mm Trephine with Handle
    3. Retinal Lagua Pick: 2.0mm Vertical Notch
    4. Infusion Cannula 2.0mm
    5. Light Guide Cables - 2.0mm
    6. Serdarevic Suture Hook
    7. Castroviejo Suture Forceps
    8. OGawa Straight Suture-Fixation Forceps - 0.12 mm
    9. Colibri Suture Removal Forceps
    10. Paton Extra Delicate Suture Forceps
    11. Suture tying forceps
    ... adjustable belt buckle. You adjust once and thats ... your shoulders. And now theres our Lady Style ... ,For additional back support try one of our ... the vertebrae and help lift the apron off ...
    The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...
    The major innovation in posterior stabilized (PS) knee design. Improve patellofemoral kinematics. Reduce wear rate potential. Increase resistance to posterior tibial dislocation. Achieve at least 120...
    StelKast's Proven™ Knee System is a long term high quality solution based on a clinically proven and successful design....
    Medicine Products:
    (Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
    (Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
    (Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
    (Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
    (Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
    Breaking Medicine News(10 mins):
    (Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
    (Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
    (Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
    Breaking Medicine Technology: